Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Hepatology. 2010 Jan;51(1):121–129. doi: 10.1002/hep.23276

Table 3.

Change in Histologic parameters after 48 weeks of intervention*

Variable Group Baseline End of Study P-value#
Fat (0-3) Control 1.9 (0.9) 1.6 (1.0) 0.02
LS 1.9 (0.7) 0.8 (0.9)
Parenchymal
Inflammation (0-3)
Control 1.7 (0.8) 1.3 (0.8) 0.18
LS 1.4 (0.6) 0.9 (0.5)
Ballooning Injury
(0-2)
Control 1.3 (0.5) 0.6 (0.7) 0.22
LS 1.2 (0.5) 0.3 (0.6)
Fibrosis (0-4) Control 1.7 (0.8) 1.4 (1.3) 0.62
LS 1.4 (1.1) 1.4 (1.0)
NAS (0-8) Control 4.9 (1.0) 3.5 (1.8) 0.05
LS 4.4 (1.1) 2.0 (1.5)
*

Control group, N=10, LS group, N=18

Data expressed as mean (SD)

#

P-value compares the mean difference between the pre- and post-treatment changes in the variables between the two groups.